ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Epilepsy Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-19R5882
Home | Market Reports | Health| Health Conditions| Neurological Conditions
Global Epilepsy Market Insights and Forecast to 2028
BUY CHAPTERS

Global Epilepsy Market Research Report 2025

Code: QYRE-Auto-19R5882
Report
September 2025
Pages:86
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
LivaNova
Johnson & Johnson Services
Eisai Co Ltd
GlaxoSmithKline PLC
Pfizer Inc
UCB SA
Medtronic plc (Ireland)
NeuroPace Inc
Novartis
GW Pharmaceuticals
Abbott Laboratories
Sanofi
Sunovion Pharmaceuticals
Bausch Health
Takeda
Johnson & Johnson Services

Epilepsy Market

The global market for Epilepsy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Epilepsy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Epilepsy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Epilepsy in Hospitals is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Epilepsy include LivaNova, Johnson & Johnson Services, Eisai, GlaxoSmithKline PLC, Pfizer, UCB SA, Medtronic PLC (Ireland), NeuroPace, Novartis AG, GW Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Epilepsy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epilepsy.
The Epilepsy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Epilepsy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epilepsy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Epilepsy Market Report

Report Metric Details
Report Name Epilepsy Market
Segment by Type
  • Partial/focal Seizure
  • Generalized Seizure
  • Myoclonus Misses
  • Negative Myoclonus
  • Eyelid Myoclonus
  • Laughter
  • Others
Segment by Application
  • Hospitals
  • Neurology Centers
  • Home Care Settings
  • Ambulatory Surgical Centers
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company LivaNova, Johnson & Johnson Services, Eisai, GlaxoSmithKline PLC, Pfizer, UCB SA, Medtronic PLC (Ireland), NeuroPace, Novartis AG, GW Pharmaceuticals, Abbott Laboratories, Sanofi, Sunovion Pharmaceuticals, Bausch Health, Takeda
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Epilepsy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Epilepsy Market report?

Ans: The main players in the Epilepsy Market are LivaNova, Johnson & Johnson Services, Eisai, GlaxoSmithKline PLC, Pfizer, UCB SA, Medtronic PLC (Ireland), NeuroPace, Novartis AG, GW Pharmaceuticals, Abbott Laboratories, Sanofi, Sunovion Pharmaceuticals, Bausch Health, Takeda

What are the Application segmentation covered in the Epilepsy Market report?

Ans: The Applications covered in the Epilepsy Market report are Hospitals, Neurology Centers, Home Care Settings, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Epilepsy Market report?

Ans: The Types covered in the Epilepsy Market report are Partial/focal Seizure, Generalized Seizure, Myoclonus Misses, Negative Myoclonus, Eyelid Myoclonus, Laughter, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epilepsy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Partial/focal Seizure
1.2.3 Generalized Seizure
1.2.4 Myoclonus Misses
1.2.5 Negative Myoclonus
1.2.6 Eyelid Myoclonus
1.2.7 Laughter
1.2.8 Others
1.3 Market by Application
1.3.1 Global Epilepsy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Neurology Centers
1.3.4 Home Care Settings
1.3.5 Ambulatory Surgical Centers
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Epilepsy Market Perspective (2020-2031)
2.2 Global Epilepsy Growth Trends by Region
2.2.1 Global Epilepsy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Epilepsy Historic Market Size by Region (2020-2025)
2.2.3 Epilepsy Forecasted Market Size by Region (2026-2031)
2.3 Epilepsy Market Dynamics
2.3.1 Epilepsy Industry Trends
2.3.2 Epilepsy Market Drivers
2.3.3 Epilepsy Market Challenges
2.3.4 Epilepsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Epilepsy Players by Revenue
3.1.1 Global Top Epilepsy Players by Revenue (2020-2025)
3.1.2 Global Epilepsy Revenue Market Share by Players (2020-2025)
3.2 Global Epilepsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Epilepsy Revenue
3.4 Global Epilepsy Market Concentration Ratio
3.4.1 Global Epilepsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epilepsy Revenue in 2024
3.5 Global Key Players of Epilepsy Head office and Area Served
3.6 Global Key Players of Epilepsy, Product and Application
3.7 Global Key Players of Epilepsy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Epilepsy Breakdown Data by Type
4.1 Global Epilepsy Historic Market Size by Type (2020-2025)
4.2 Global Epilepsy Forecasted Market Size by Type (2026-2031)
5 Epilepsy Breakdown Data by Application
5.1 Global Epilepsy Historic Market Size by Application (2020-2025)
5.2 Global Epilepsy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Epilepsy Market Size (2020-2031)
6.2 North America Epilepsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Epilepsy Market Size by Country (2020-2025)
6.4 North America Epilepsy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Epilepsy Market Size (2020-2031)
7.2 Europe Epilepsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Epilepsy Market Size by Country (2020-2025)
7.4 Europe Epilepsy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Epilepsy Market Size (2020-2031)
8.2 Asia-Pacific Epilepsy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Epilepsy Market Size by Region (2020-2025)
8.4 Asia-Pacific Epilepsy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Epilepsy Market Size (2020-2031)
9.2 Latin America Epilepsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Epilepsy Market Size by Country (2020-2025)
9.4 Latin America Epilepsy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Epilepsy Market Size (2020-2031)
10.2 Middle East & Africa Epilepsy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Epilepsy Market Size by Country (2020-2025)
10.4 Middle East & Africa Epilepsy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 LivaNova
11.1.1 LivaNova Company Details
11.1.2 LivaNova Business Overview
11.1.3 LivaNova Epilepsy Introduction
11.1.4 LivaNova Revenue in Epilepsy Business (2020-2025)
11.1.5 LivaNova Recent Development
11.2 Johnson & Johnson Services
11.2.1 Johnson & Johnson Services Company Details
11.2.2 Johnson & Johnson Services Business Overview
11.2.3 Johnson & Johnson Services Epilepsy Introduction
11.2.4 Johnson & Johnson Services Revenue in Epilepsy Business (2020-2025)
11.2.5 Johnson & Johnson Services Recent Development
11.3 Eisai
11.3.1 Eisai Company Details
11.3.2 Eisai Business Overview
11.3.3 Eisai Epilepsy Introduction
11.3.4 Eisai Revenue in Epilepsy Business (2020-2025)
11.3.5 Eisai Recent Development
11.4 GlaxoSmithKline PLC
11.4.1 GlaxoSmithKline PLC Company Details
11.4.2 GlaxoSmithKline PLC Business Overview
11.4.3 GlaxoSmithKline PLC Epilepsy Introduction
11.4.4 GlaxoSmithKline PLC Revenue in Epilepsy Business (2020-2025)
11.4.5 GlaxoSmithKline PLC Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Epilepsy Introduction
11.5.4 Pfizer Revenue in Epilepsy Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 UCB SA
11.6.1 UCB SA Company Details
11.6.2 UCB SA Business Overview
11.6.3 UCB SA Epilepsy Introduction
11.6.4 UCB SA Revenue in Epilepsy Business (2020-2025)
11.6.5 UCB SA Recent Development
11.7 Medtronic PLC (Ireland)
11.7.1 Medtronic PLC (Ireland) Company Details
11.7.2 Medtronic PLC (Ireland) Business Overview
11.7.3 Medtronic PLC (Ireland) Epilepsy Introduction
11.7.4 Medtronic PLC (Ireland) Revenue in Epilepsy Business (2020-2025)
11.7.5 Medtronic PLC (Ireland) Recent Development
11.8 NeuroPace
11.8.1 NeuroPace Company Details
11.8.2 NeuroPace Business Overview
11.8.3 NeuroPace Epilepsy Introduction
11.8.4 NeuroPace Revenue in Epilepsy Business (2020-2025)
11.8.5 NeuroPace Recent Development
11.9 Novartis AG
11.9.1 Novartis AG Company Details
11.9.2 Novartis AG Business Overview
11.9.3 Novartis AG Epilepsy Introduction
11.9.4 Novartis AG Revenue in Epilepsy Business (2020-2025)
11.9.5 Novartis AG Recent Development
11.10 GW Pharmaceuticals
11.10.1 GW Pharmaceuticals Company Details
11.10.2 GW Pharmaceuticals Business Overview
11.10.3 GW Pharmaceuticals Epilepsy Introduction
11.10.4 GW Pharmaceuticals Revenue in Epilepsy Business (2020-2025)
11.10.5 GW Pharmaceuticals Recent Development
11.11 Abbott Laboratories
11.11.1 Abbott Laboratories Company Details
11.11.2 Abbott Laboratories Business Overview
11.11.3 Abbott Laboratories Epilepsy Introduction
11.11.4 Abbott Laboratories Revenue in Epilepsy Business (2020-2025)
11.11.5 Abbott Laboratories Recent Development
11.12 Sanofi
11.12.1 Sanofi Company Details
11.12.2 Sanofi Business Overview
11.12.3 Sanofi Epilepsy Introduction
11.12.4 Sanofi Revenue in Epilepsy Business (2020-2025)
11.12.5 Sanofi Recent Development
11.13 Sunovion Pharmaceuticals
11.13.1 Sunovion Pharmaceuticals Company Details
11.13.2 Sunovion Pharmaceuticals Business Overview
11.13.3 Sunovion Pharmaceuticals Epilepsy Introduction
11.13.4 Sunovion Pharmaceuticals Revenue in Epilepsy Business (2020-2025)
11.13.5 Sunovion Pharmaceuticals Recent Development
11.14 Bausch Health
11.14.1 Bausch Health Company Details
11.14.2 Bausch Health Business Overview
11.14.3 Bausch Health Epilepsy Introduction
11.14.4 Bausch Health Revenue in Epilepsy Business (2020-2025)
11.14.5 Bausch Health Recent Development
11.15 Takeda
11.15.1 Takeda Company Details
11.15.2 Takeda Business Overview
11.15.3 Takeda Epilepsy Introduction
11.15.4 Takeda Revenue in Epilepsy Business (2020-2025)
11.15.5 Takeda Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
LivaNova
Johnson & Johnson Services
Eisai Co Ltd
GlaxoSmithKline PLC
Pfizer Inc
UCB SA
Medtronic plc (Ireland)
NeuroPace Inc
Novartis
GW Pharmaceuticals
Abbott Laboratories
Sanofi
Sunovion Pharmaceuticals
Bausch Health
Takeda
Johnson & Johnson Services
List of Tables
 Table 1. Global Epilepsy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Partial/focal Seizure
 Table 3. Key Players of Generalized Seizure
 Table 4. Key Players of Myoclonus Misses
 Table 5. Key Players of Negative Myoclonus
 Table 6. Key Players of Eyelid Myoclonus
 Table 7. Key Players of Laughter
 Table 8. Key Players of Others
 Table 9. Global Epilepsy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 10. Global Epilepsy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 11. Global Epilepsy Market Size by Region (2020-2025) & (US$ Million)
 Table 12. Global Epilepsy Market Share by Region (2020-2025)
 Table 13. Global Epilepsy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 14. Global Epilepsy Market Share by Region (2026-2031)
 Table 15. Epilepsy Market Trends
 Table 16. Epilepsy Market Drivers
 Table 17. Epilepsy Market Challenges
 Table 18. Epilepsy Market Restraints
 Table 19. Global Epilepsy Revenue by Players (2020-2025) & (US$ Million)
 Table 20. Global Epilepsy Market Share by Players (2020-2025)
 Table 21. Global Top Epilepsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy as of 2024)
 Table 22. Ranking of Global Top Epilepsy Companies by Revenue (US$ Million) in 2024
 Table 23. Global 5 Largest Players Market Share by Epilepsy Revenue (CR5 and HHI) & (2020-2025)
 Table 24. Global Key Players of Epilepsy, Headquarters and Area Served
 Table 25. Global Key Players of Epilepsy, Product and Application
 Table 26. Global Key Players of Epilepsy, Date of Enter into This Industry
 Table 27. Mergers & Acquisitions, Expansion Plans
 Table 28. Global Epilepsy Market Size by Type (2020-2025) & (US$ Million)
 Table 29. Global Epilepsy Revenue Market Share by Type (2020-2025)
 Table 30. Global Epilepsy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 31. Global Epilepsy Revenue Market Share by Type (2026-2031)
 Table 32. Global Epilepsy Market Size by Application (2020-2025) & (US$ Million)
 Table 33. Global Epilepsy Revenue Market Share by Application (2020-2025)
 Table 34. Global Epilepsy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 35. Global Epilepsy Revenue Market Share by Application (2026-2031)
 Table 36. North America Epilepsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. North America Epilepsy Market Size by Country (2020-2025) & (US$ Million)
 Table 38. North America Epilepsy Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Europe Epilepsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Europe Epilepsy Market Size by Country (2020-2025) & (US$ Million)
 Table 41. Europe Epilepsy Market Size by Country (2026-2031) & (US$ Million)
 Table 42. Asia-Pacific Epilepsy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Asia-Pacific Epilepsy Market Size by Region (2020-2025) & (US$ Million)
 Table 44. Asia-Pacific Epilepsy Market Size by Region (2026-2031) & (US$ Million)
 Table 45. Latin America Epilepsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Latin America Epilepsy Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Latin America Epilepsy Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Middle East & Africa Epilepsy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 49. Middle East & Africa Epilepsy Market Size by Country (2020-2025) & (US$ Million)
 Table 50. Middle East & Africa Epilepsy Market Size by Country (2026-2031) & (US$ Million)
 Table 51. LivaNova Company Details
 Table 52. LivaNova Business Overview
 Table 53. LivaNova Epilepsy Product
 Table 54. LivaNova Revenue in Epilepsy Business (2020-2025) & (US$ Million)
 Table 55. LivaNova Recent Development
 Table 56. Johnson & Johnson Services Company Details
 Table 57. Johnson & Johnson Services Business Overview
 Table 58. Johnson & Johnson Services Epilepsy Product
 Table 59. Johnson & Johnson Services Revenue in Epilepsy Business (2020-2025) & (US$ Million)
 Table 60. Johnson & Johnson Services Recent Development
 Table 61. Eisai Company Details
 Table 62. Eisai Business Overview
 Table 63. Eisai Epilepsy Product
 Table 64. Eisai Revenue in Epilepsy Business (2020-2025) & (US$ Million)
 Table 65. Eisai Recent Development
 Table 66. GlaxoSmithKline PLC Company Details
 Table 67. GlaxoSmithKline PLC Business Overview
 Table 68. GlaxoSmithKline PLC Epilepsy Product
 Table 69. GlaxoSmithKline PLC Revenue in Epilepsy Business (2020-2025) & (US$ Million)
 Table 70. GlaxoSmithKline PLC Recent Development
 Table 71. Pfizer Company Details
 Table 72. Pfizer Business Overview
 Table 73. Pfizer Epilepsy Product
 Table 74. Pfizer Revenue in Epilepsy Business (2020-2025) & (US$ Million)
 Table 75. Pfizer Recent Development
 Table 76. UCB SA Company Details
 Table 77. UCB SA Business Overview
 Table 78. UCB SA Epilepsy Product
 Table 79. UCB SA Revenue in Epilepsy Business (2020-2025) & (US$ Million)
 Table 80. UCB SA Recent Development
 Table 81. Medtronic PLC (Ireland) Company Details
 Table 82. Medtronic PLC (Ireland) Business Overview
 Table 83. Medtronic PLC (Ireland) Epilepsy Product
 Table 84. Medtronic PLC (Ireland) Revenue in Epilepsy Business (2020-2025) & (US$ Million)
 Table 85. Medtronic PLC (Ireland) Recent Development
 Table 86. NeuroPace Company Details
 Table 87. NeuroPace Business Overview
 Table 88. NeuroPace Epilepsy Product
 Table 89. NeuroPace Revenue in Epilepsy Business (2020-2025) & (US$ Million)
 Table 90. NeuroPace Recent Development
 Table 91. Novartis AG Company Details
 Table 92. Novartis AG Business Overview
 Table 93. Novartis AG Epilepsy Product
 Table 94. Novartis AG Revenue in Epilepsy Business (2020-2025) & (US$ Million)
 Table 95. Novartis AG Recent Development
 Table 96. GW Pharmaceuticals Company Details
 Table 97. GW Pharmaceuticals Business Overview
 Table 98. GW Pharmaceuticals Epilepsy Product
 Table 99. GW Pharmaceuticals Revenue in Epilepsy Business (2020-2025) & (US$ Million)
 Table 100. GW Pharmaceuticals Recent Development
 Table 101. Abbott Laboratories Company Details
 Table 102. Abbott Laboratories Business Overview
 Table 103. Abbott Laboratories Epilepsy Product
 Table 104. Abbott Laboratories Revenue in Epilepsy Business (2020-2025) & (US$ Million)
 Table 105. Abbott Laboratories Recent Development
 Table 106. Sanofi Company Details
 Table 107. Sanofi Business Overview
 Table 108. Sanofi Epilepsy Product
 Table 109. Sanofi Revenue in Epilepsy Business (2020-2025) & (US$ Million)
 Table 110. Sanofi Recent Development
 Table 111. Sunovion Pharmaceuticals Company Details
 Table 112. Sunovion Pharmaceuticals Business Overview
 Table 113. Sunovion Pharmaceuticals Epilepsy Product
 Table 114. Sunovion Pharmaceuticals Revenue in Epilepsy Business (2020-2025) & (US$ Million)
 Table 115. Sunovion Pharmaceuticals Recent Development
 Table 116. Bausch Health Company Details
 Table 117. Bausch Health Business Overview
 Table 118. Bausch Health Epilepsy Product
 Table 119. Bausch Health Revenue in Epilepsy Business (2020-2025) & (US$ Million)
 Table 120. Bausch Health Recent Development
 Table 121. Takeda Company Details
 Table 122. Takeda Business Overview
 Table 123. Takeda Epilepsy Product
 Table 124. Takeda Revenue in Epilepsy Business (2020-2025) & (US$ Million)
 Table 125. Takeda Recent Development
 Table 126. Research Programs/Design for This Report
 Table 127. Key Data Information from Secondary Sources
 Table 128. Key Data Information from Primary Sources
 Table 129. Authors List of This Report


List of Figures
 Figure 1. Epilepsy Picture
 Figure 2. Global Epilepsy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Epilepsy Market Share by Type: 2024 VS 2031
 Figure 4. Partial/focal Seizure Features
 Figure 5. Generalized Seizure Features
 Figure 6. Myoclonus Misses Features
 Figure 7. Negative Myoclonus Features
 Figure 8. Eyelid Myoclonus Features
 Figure 9. Laughter Features
 Figure 10. Others Features
 Figure 11. Global Epilepsy Market Size by Application (2020-2031) & (US$ Million)
 Figure 12. Global Epilepsy Market Share by Application: 2024 VS 2031
 Figure 13. Hospitals Case Studies
 Figure 14. Neurology Centers Case Studies
 Figure 15. Home Care Settings Case Studies
 Figure 16. Ambulatory Surgical Centers Case Studies
 Figure 17. Others Case Studies
 Figure 18. Epilepsy Report Years Considered
 Figure 19. Global Epilepsy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 20. Global Epilepsy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 21. Global Epilepsy Market Share by Region: 2024 VS 2031
 Figure 22. Global Epilepsy Market Share by Players in 2024
 Figure 23. Global Top Epilepsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epilepsy as of 2024)
 Figure 24. The Top 10 and 5 Players Market Share by Epilepsy Revenue in 2024
 Figure 25. North America Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. North America Epilepsy Market Share by Country (2020-2031)
 Figure 27. United States Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Canada Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Europe Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Europe Epilepsy Market Share by Country (2020-2031)
 Figure 31. Germany Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. France Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. U.K. Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Italy Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Russia Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Nordic Countries Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Asia-Pacific Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Asia-Pacific Epilepsy Market Share by Region (2020-2031)
 Figure 39. China Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Japan Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. South Korea Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. India Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Australia Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Latin America Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Latin America Epilepsy Market Share by Country (2020-2031)
 Figure 47. Mexico Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Brazil Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Middle East & Africa Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Middle East & Africa Epilepsy Market Share by Country (2020-2031)
 Figure 51. Turkey Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 53. UAE Epilepsy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 54. LivaNova Revenue Growth Rate in Epilepsy Business (2020-2025)
 Figure 55. Johnson & Johnson Services Revenue Growth Rate in Epilepsy Business (2020-2025)
 Figure 56. Eisai Revenue Growth Rate in Epilepsy Business (2020-2025)
 Figure 57. GlaxoSmithKline PLC Revenue Growth Rate in Epilepsy Business (2020-2025)
 Figure 58. Pfizer Revenue Growth Rate in Epilepsy Business (2020-2025)
 Figure 59. UCB SA Revenue Growth Rate in Epilepsy Business (2020-2025)
 Figure 60. Medtronic PLC (Ireland) Revenue Growth Rate in Epilepsy Business (2020-2025)
 Figure 61. NeuroPace Revenue Growth Rate in Epilepsy Business (2020-2025)
 Figure 62. Novartis AG Revenue Growth Rate in Epilepsy Business (2020-2025)
 Figure 63. GW Pharmaceuticals Revenue Growth Rate in Epilepsy Business (2020-2025)
 Figure 64. Abbott Laboratories Revenue Growth Rate in Epilepsy Business (2020-2025)
 Figure 65. Sanofi Revenue Growth Rate in Epilepsy Business (2020-2025)
 Figure 66. Sunovion Pharmaceuticals Revenue Growth Rate in Epilepsy Business (2020-2025)
 Figure 67. Bausch Health Revenue Growth Rate in Epilepsy Business (2020-2025)
 Figure 68. Takeda Revenue Growth Rate in Epilepsy Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Global Epilepsy in Children Market Research Report 2024
Global Portable Epilepsy Monitoring Market Research Report 2024
Global Epileptic Seizures Treatment Market Research Report 2024
Global Epilepsy Surgery Service Market Research Report 2025
Routine Epilepsy Monitoring Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Epilepsy Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Epilepsy Detection Alert Device Market Research Report 2025
Global Epilepsy Monitoring Unit EMU Market Research Report 2025
Anticonvulsant Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global EEG Systems Market Research Report 2024
Status Epilepticus Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Carbamazepine Tablets Market Research Report 2024
Global Video EEG Market Research Report 2024
Paediatric Epilepsy Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti Epileptic Pharmaceutical Intermediates Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global EEG Caps Market Research Report 2024
Global EEG Patient Monitor Market Research Report 2024
Global EEG Acquisition System Market Research Report 2024
Global EPIRBs Market Research Report 2024
Global Patient EEG Monitors Market Research Report 2024

RELATED REPORTS

Global Attention Deficit Hyperactivity Disorder (ADHD) Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13Z8760
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Intracranial Pressure (ICP) Monitoring Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-37L4006
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Brain Disease Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12P6151
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3X6389
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions